The impact of disease and treatment on the patient’s overall well-being and functioning is a topic of growing interest in clinical research and practice. The aim of this study is to obtain reference data on quality of life of Croatian general population. Further, we aim to assess the impact of the disease and its primary systemic treatment on their health related quality of life (HrQoL) in multiple myeloma (MM) patients
In the Medical Research Council (MRC) Myeloma IX trial (ISRCTN684564111) patients were randomised to...
The PROFILES registry offers scientific data in the area of medical psychology and more specific on ...
Multiple myeloma is the second most common haematological malignancy. Novel therapies have led to im...
Background: The impact of disease and treatment on the patient’s overall well-being and functioning ...
Unfortunately, multiple myeloma is still an incurable disease. The therapeutic aim is to reduce tumo...
Background: Reliable and validated instruments are needed in order to study the quality of life in m...
Multipli mijelom je maligna bolest koštane srži karakterizirana neoplastičnom proliferacijom plazma ...
Im Rahmen dieser Studie wurde die Lebensqualität (QoL) von Patienten mit Multiplem Myelom zu verschi...
Objective: The situation of patients with multiple myeloma, whose treatment often implies high-dose ...
SummaryBackgroundQuality of life (QoL) is defined as “a patient's subjective evaluation of his life ...
textabstractIn multiple myeloma (MM), health-related quality of life (HRQoL) data is becoming increa...
Objective:The aim of this study was the validation of the European Organization for Research and Tre...
The PROFILES registry offers scientific data in the area of medical psychology and more specific on ...
Tıpta Uzmanlık TeziBu çalışmada, multipl miyelom hastalarında hastalığın kendisinden ve uygulanan çe...
The aim of this study was to determine the prevalence of symptoms and problems in hospitalized hemat...
In the Medical Research Council (MRC) Myeloma IX trial (ISRCTN684564111) patients were randomised to...
The PROFILES registry offers scientific data in the area of medical psychology and more specific on ...
Multiple myeloma is the second most common haematological malignancy. Novel therapies have led to im...
Background: The impact of disease and treatment on the patient’s overall well-being and functioning ...
Unfortunately, multiple myeloma is still an incurable disease. The therapeutic aim is to reduce tumo...
Background: Reliable and validated instruments are needed in order to study the quality of life in m...
Multipli mijelom je maligna bolest koštane srži karakterizirana neoplastičnom proliferacijom plazma ...
Im Rahmen dieser Studie wurde die Lebensqualität (QoL) von Patienten mit Multiplem Myelom zu verschi...
Objective: The situation of patients with multiple myeloma, whose treatment often implies high-dose ...
SummaryBackgroundQuality of life (QoL) is defined as “a patient's subjective evaluation of his life ...
textabstractIn multiple myeloma (MM), health-related quality of life (HRQoL) data is becoming increa...
Objective:The aim of this study was the validation of the European Organization for Research and Tre...
The PROFILES registry offers scientific data in the area of medical psychology and more specific on ...
Tıpta Uzmanlık TeziBu çalışmada, multipl miyelom hastalarında hastalığın kendisinden ve uygulanan çe...
The aim of this study was to determine the prevalence of symptoms and problems in hospitalized hemat...
In the Medical Research Council (MRC) Myeloma IX trial (ISRCTN684564111) patients were randomised to...
The PROFILES registry offers scientific data in the area of medical psychology and more specific on ...
Multiple myeloma is the second most common haematological malignancy. Novel therapies have led to im...